Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.
Fintech major BharatPe’s chief marketing officer Parth Joshi is stepping down from his position to ‘pursue an entrepreneurial ...
6d
9News.com.au on MSNFire crews battle massive factory blaze in Melbourne's south-eastThis joint project of South Korea and Indonesia has been plagued with issues throughout the years and many doubted its ...
February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...
Advertisers are turning to creative strategies to capture attention ahead of the showdown between the Philadelphia Eagles and ...
Banco Santander (BME: SAN) shares spiked over 6% on Wednesday after the lender unveiled plans for €10 billion (£8.3 billion) ...
The decision is remarkable in that the HIV integrase inhibitor is one of ViiV’s most up-to-date products, only getting FDA approval under the Apretude brand ... GSK also said the new agreements ...
GSK plc (LSE/NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has today announced that the European ...
One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...
London: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as ...
2d
GlobalData on MSNViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisationThe European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...
“We respect Parth Joshi’s decision to start his entrepreneurial journey,” a BharatPe spokesperson confirmed. At BharatPe, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results